Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015 Aug 14;6(23):19405-12.
doi: 10.18632/oncotarget.3740.

Rejuvenating immunity: "anti-aging drug today" eight years later

Mikhail V Blagosklonny  1
Affiliations

Rejuvenating immunity: "anti-aging drug today" eight years later

Mikhail V Blagosklonny. Oncotarget. .

Abstract

The 2014 year ended with celebration: Everolimus, a rapamycin analog, was shown to improve immunity in old humans, heralding "a turning point" in research and new era in human quest for immortality. Yet, this turning point was predicted a decade ago. But what will cause human death, when aging will be abolished?

Keywords: TOR; diseases; gerosuppression; lifespan; longevity; mTOR; rapalogs.

PubMed Disclaimer

References

    1. Rattan SIS. Anti-ageing strategies: prevention or therapy. EMBO Rep. 2005;6:S25–29. - PMC - PubMed
    1. Blagosklonny MV. Aging and immortality: quasi-programmed senescence and its pharmacologic inhibition. Cell Cycle. 2006;5:2087–2102. - PubMed
    1. Blagosklonny MV. An anti-aging drug today: from senescence-promoting genes to anti-aging pill. Drug Disc Today. 2007;12:218–224. - PubMed
    1. Blagosklonny MV. Aging: ROS or TOR. Cell Cycle. 2008;7:3344–3354. - PubMed
    1. Mannick JB, Del Giudice G, Lattanzi M, Valiante NM, Praestgaard J, Huang B, Lonetto MA, Maecker HT, Kovarik J, Carson S, Glass DJ, Klickstein LB. mTOR inhibition improves immune function in the elderly. Sci Transl Med. 6:268ra179. - PubMed